<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0013">
 <label>13.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Chen</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Cheng</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Yuan</surname>
   <given-names>Z</given-names>
  </string-name>, 
  <string-name>
   <surname>Wang</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Yang</surname>
   <given-names>L</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhao</surname>
   <given-names>H</given-names>
  </string-name>. 
  <article-title>NCK1-AS1 increases drug resistance of glioma cells to temozolomide by modulating miR-137/TRIM24</article-title>. 
  <source>
   <italic toggle="yes">Cancer Biother Radiopharm</italic>
  </source>. 
  <year>2020</year>;
  <volume>35</volume>(
  <issue>2</issue>):
  <fpage>101</fpage>â€“
  <lpage>108</lpage>. doi:
  <pub-id pub-id-type="doi">10.1089/cbr.2019.3054</pub-id>
  <pub-id pub-id-type="pmid">31750728</pub-id>
 </mixed-citation>
</ref>
